GENETIC ANALYSIS AND FERRING PHARMACEUTICALS ANNOUNCE A COLLABORATION TO DEVELOP A NEW MICROBIOME RAPID DIAGNOSTIC TEST December 21, 2024
Spermosens recruits first couple for clinical study on next-generation male fertility diagnostic product October 4, 2024
Spermosens next-generation male fertility diagnostic product ready for clinical study September 25, 2024
Fujirebio Submits FDA Regulatory Filing for Lumipulse® G pTau 217/ß-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease September 25, 2024
